ArticleScientific reports2025
Machine learning-based analysis on pharmaceutical compounds interaction with polymer to estimate drug solubility in formulations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Discovering interpretable drug formulation behavior patterns via a mechanistic-augmented conditional variational autoencoder.Scientific reports · 2026Article
- Accelerating supercritical pharmaceutical formulation via interpretable data-driven prediction of drug solubility.Scientific reports · 2026Article
- Artificial neural network as a strategy to predict rheological properties in emulgel formulations.Scientific reports · 2026Article
- Theoretical analysis of MOFs for pharmaceutical applications by using machine learning models to predict loading capacity and cell viability.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This study introduces a sophisticated predictive framework for determining drug solubility and activity values in formulations via machine learning. The framework utilizes a comprehensive dataset consisting of more than 12,000 data rows and 24 input features containing a wide range of parameters to estimate drug solubility in formulation. The primary goal is to improve the accuracy of predictions by using ensemble learning techniques. Three base models were evaluated including: Decision Tree (DT), K-Nearest Neighbors (KNN), and Multilayer Perceptron (MLP), which are subsequently improved with the AdaBoost ensemble method. To further optimize performance, Recursive Feature Elimination (RFE) is employed for feature selection with the number of features treated as a hyperparameter. Hyperparameter tuning is rigorously conducted utilizing the Harmony Search (HS) algorithm. For drug solubility prediction, the ADA-DT model demonstrates superior performance, achieving an R² score of 0.9738 on the test set, with a Mean Squared Error (MSE) of 5.4270E-04 and a Mean Absolute Error (MAE) of 2.10921E-02. For gamma prediction, the ADA-KNN model outperforms other models, with an R² value of 0.9545 on the test set, an MSE of 4.5908E-03, and a MAE of 1.42730E-02. The results show that ensemble learning with advanced feature selection and hyperparameter optimization can accurately predict complex biochemical properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.